Skip to content

Agenda

6:30 – 7:30 am Registration Check-In Breakfast
7:30 – 7:45 am Welcome & Chairman’s Opening Remarks
Followed by 2013 Year in Review
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures
Gilbert Kliman, MD, Managing Director – InterWest Partners
William J. Link, PhD, Managing Director – Versant Ventures
7:45 – 9:21 am Private Device Company Showcase
Co-Moderators:
Murthy V. Simhambhatla, PhD, Senior Vice President – Abbott Medical Group
James Garvey, Chairman & Managing Partner – SV Life Sciences

7:45-7:53 – i-Optics Corporation – Jeroen Cammeraat, CEO
7:53-8:01 – Notal Vision – Scott Jones, President
8:01-8:09 – Clarity Medical – Keith Mullowney, Chairman & CEO
8:09-8:17 – WaveTec Vision Systems – Thomas Frinzi, President & CEO
8:17-8:25 – Refocus Group – Mike Judy, President & CEO
8:25-8:33 – PowerVision – Barry Cheskin, President & CEO
8:33-8:41 – AkkoLens International BV – Michiel Rombach, CEO
8:41-8:49 – AcuFocus – Nicholas Tarantino, OD, Chief Clinical & Regulatory Officer
8:49-8:57 – ClarVista Medical – Paul McLean, President & CEO
8:57-9:05 – Sinopsys Surgical – Harry Ross, President & CEO
9:05-9:13 – Sensimed AG – Jean-Marc Wismer, CEO
9:13-9:21 – Avedro – David Muller, PhD, President & CEO
9:21 – 9:50 am Morning Refreshment & Networking Break
9:50 – 11:34 am Private BioPharma Company Showcase
Co-Moderators:
Theresa GH Heah, MD, Director of Brand Management & Global Marketing Ophthalmology – Bayer HealthCare Pharmaceuticals
Neil Levine, Sr. Director, Marketing – Regeneron Pharmaceuticals

9:50-9:58 – Aerie Pharmaceuticals – Vicente Anido Jr., PhD, Chairman & CEO
9:58-10:06 – Amakem Therapeutics – Jack Elands, CEO
10:06-10:14 – Ocular Therapeutix – Amarpreet Sawhney, President & CEO
10:14-10:22 – RXi Pharmaceuticals – Geert Cauwenbergh, President & CEO
10:22-10:30 – Ophthotech Corporation – David Guyer, CEO
10:30-10:38 – Neurotech – Ted Danse, President & CEO
10:38-10:46 – Allegro Ophthalmics – Vicken Karageozian, Co-Founder & CTO
10:46-10:54 – PanOptica – Paul Chaney, President & CEO
10:54-11:02 – iCo Therapeutics – Andrew Rae, President & CEO
11:02-11:10 – Novaliq GmbH – Bernhard Gunther, CEO
11:10-11:18 – Eleven Biotherapeutics – Abbie Celniker, CEO
11:18-11:26 – Icon BioSciences – William S. (Sandy) White, President & CEO
11:26-11:34 – Kala Pharmaceuticals – Guillaume Pfefer, President & CEO
11:34 – 11:59 am Mobile Ophthalmic Technology Showcase
Moderator:
Gilbert Kliman, MD, Managing Director – InterWest Partners

11:34-11:36 – Gobiquity Mobile Health – Michael Brownell, CEO
11:36-11:44 – Digisight – Doug Foster, CEO
11:44-11:49 – CheckedUp – Richard Awdeh, MD, Founder & CEO
11:49-11:54 – EyeNetra – David Schafran, Co-Founder & COO
11:54-11:59 – KeepYourSight – Marie Alexander, CEO
11:59 am – 12:06 pm The Ophthalmology Market
A View from the Public Sector
Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan
12:06 – 12:13 pm Private Funding & Exit Trends
Jonathan Norris, Managing Director – SVB Capital
12:13 – 12:20 pm US vs. EU
A Venture Perspective
William J. Link, PhD, Managing Director – Versant Ventures
12:20 pm Luncheon Commences
1:00 – 1:25 pm Keynote: Sustaining Innovation in Ophthalmology
A View From the Top
David E.I. Pyott, Chairman of the Board & CEO – Allergan
1:25 – 1:50 pm OIS Innovator Award
Recipients:
Thomas Burns, President & CEO – Glaukos
Richard Hill, MD, Co-Founder – Glaukos
1:50 – 2:00 pm Coffee & Networking
2:00 pm Luncheon Concludes
2:00 – 2:07 pm Ophthalmic Innovation 2013
A View from the NEI
Paul Sieving, MD, Director – National Eye Institute, National Institutes of Health
2:07 – 2:50 pm Ophthalmic Innovation 2013
A View from the AAO
David W. Parke, MD, CEO – American Academy of Ophthalmology
2:15 – 2:50 pm Developing an Effective Dialogue with the FDA
Moderator:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures

Panel Members:
Wiley A. Chambers, MD, Deputy Director of the Division of Transplant & Ophthalmology Products, Center for Drug Evaluation & Research – FDA
Malvina B. Eydelman, MD, Director, Division of Ophthalmic, Neurological & Ear, Nose & Throat Devices Office, Device Evaluation Center of Devices & Radiological Health – FDA
2:50 – 3:20 pm Alternative Financing Strategies
Moderator:
Charles Warden, Managing Director – Versant Ventures

Panel Members:
Luke Duster, Principal – Capital Royalty
Gregory Shearer, Managing Director – Healthios Capital Markets
Brian Demmert, Managing Partner – Armentum Partners
Buzz Benson, Managing Director – Sightline Partners
3:20 – 3:50 pm EU Commercialization Strategies
Moderator:
Gilbert Kliman, MD, Managing Director – InterWest Partners

Panel Members:
Laurent Attias, Head, Global Commercial Strategy – Alcon
David Muller, President & CEO – Avedro
David E.I. Pyott, Chairman of the Board & CEO – Allergan
James Mazzo, Operating Partner – Versant Ventures (Chairman – AcuFocus)
3:50 – 4:20 pm Afternoon Refreshment & Networking Break
4:20 – 5:00 pm Physician Entrepreneurship in Ophthalmology
Moderator:
Richard L. Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants

Panel Members:
Mark S. Blumenkranz, MD, Professor & Chairman of the Department of Ophthalmology – Stanford University
Eugene de Juan, MD, Founder & Vice Chairman – ForSight Labs
David L. Epstein, MD, MMM, Joseph A.C. Wadsworth Clinical Professor of Ophthalmology & Chairman of Duke Eye Center – Duke University School of Medicine
Steve Charles, MD, CEO – CamPlex
Daniel Durrie, MD, Founder & President – Durrie Vision
5:00 – 5:30 pm Going Public
Who, When & Why?
Moderator:
David R. Guyer, MD, Chief Executive Officer – Ophthotech

Panel Members:
Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan
Dan Myers, Co-Founder, President & CEO – Alimera Sciences
Nicholas Galakatos, PhD, Managing Director – Clarus Ventures
David E. Redlick, Partner & Co-Chair of the Life Sciences Group – WilmerHale
Chris Cooley, CFA, Managing Director – Stephens
5:30 – 5:35 pm Wrap Up & Closing Comments
Emmett Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures
Gilbert Kliman, MD, Managing Director – InterWest Partners
William J. Link, PhD, Managing Director – Versant Ventures
5:35 – 7:00 pm Networking Reception
Scroll To Top